BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
4.085
-0.055 (-1.33%)
At close: Jul 1, 2026, 4:00 PM EDT
3.915
-0.170 (-4.15%)
After-hours: Jul 1, 2026, 6:54 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $6.78 million as of July 1, 2026. Its market cap has decreased by -70.99% in one year.
Market Cap
6.78M
Enterprise Value
10.91M
1-Year Change
-70.99%
Ranking
Category
Stock Price
$4.09
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $9.78B to $6.78M, a decrease of -99.93%. That is a compound annual growth rate of -73.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 6.78M | -79.77% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -86.61% |
| Dec 30, 2022 | 880.59M | -59.20% |
| Dec 31, 2021 | 2.16B | -40.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenetic Biosciences | 6.83M |
| NuCana | 6.70M |
| HCW Biologics | 6.66M |
| Silo Pharma | 6.63M |
| AIM ImmunoTech | 6.48M |
| Addex Therapeutics | 6.47M |
| Can-Fite BioPharma | 6.41M |
| Aptorum Group | 6.31M |